期刊文献+

D-二聚体水平变化对肺炎支原体肺炎患儿的临床意义 被引量:10

Clinical significance of D-dimer level in children with mycoplasma pneumoniae pneumonia
下载PDF
导出
摘要 目的探讨D-二聚体水平变化对肺炎支原体肺炎(MPP)病情严重程度的意义。方法回顾性分析2016年1月—2019年12月首都医科大学附属北京儿童医院357例MPP住院患儿的临床资料,根据不同血浆D-二聚体水平将患儿分为3组。比较3组患儿的乳酸脱氢酶(LDH)、红细胞沉降率(ESR)、C反应蛋白(CRP)、白细胞(WBC)、血小板(PLT)、凝血酶原时间(PT)、纤维蛋白原定量(FIB)、部分凝血活酶时间(APTT)及抗凝酶Ⅲ活性(AT-Ⅲ);比较有无肺内并发症患儿的D-二聚体水平;研究D-二聚体水平与炎症指标、凝血功能及肺内并发症之间的关系。结果MPP患儿中,D-二聚体<0.729 mg/L 142例,D-二聚体为0.729~1.458 mg/L 97例,D-二聚体>1.458 mg/L 118例。MPP患儿血浆D-二聚体水平与CRP、LDH、是否伴有胸腔积液呈正相关(P<0.05),与APTT、AT-Ⅲ呈负相关(P<0.05)。MPP患儿D-二聚体>0.729 mg/L高度提示SMPP的可能性;D-二聚体水平越高,合并肺内并发症概率越高。结论血浆D-二聚体可作为早期SMPP的判断指标之一,能够反映MPP的严重程度,为临床治疗和监测提供依据。 Objective To explore the significance of D-dimer level changes on the severity of Mycoplasma pneumoniae pneumonia(MPP).Methods Retrospective analysis of 357 hospitalized children with MPP from January 2016 to December 2019 in Beijing Children's Hospital,Capital Medical University was performed.According to the level of plasma D-dimer,the children were divided into three groups to study the relationship of the level of plasma D-dimer and inflammation index,coagulation function,and pulmonary complications with children with MPP.Results Among 357 cases of MPP,D-dimer of 142 cases were<0.729 mg/L,97 cases were 0.729 to 1.458 mg/L,118 cases were>1.458 mg/L.Plasma D-dimer level was positively correlated with CRP,LDH,and pleural effusion(P<0.05),and negatively correlated with APTT and AT-Ⅲ(P<0.05).D-dimer>0.729 mg/L in MPP children highly suggested the possibility of SMPP;the higher the level of D-dimer,the higher the probability of pulmonary complications.Conclusion Plasma D-dimer can be used as one of the early indicators of SMPP,which can reflect the severity of MPP and provide the basis for clinical treatment and monitoring.
作者 侯月 王俊宏 陈芳 曹童童 Yue Hou;Jun-hong Wang;Fang Chen;Tong-tong Cao(Beijing Children's Hospital Affiliated to Capital Medical University(National Center for Children's Health,China),Beijing 100045,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)
出处 《中国现代医学杂志》 CAS 北大核心 2021年第13期83-87,共5页 China Journal of Modern Medicine
基金 北京中医药大学王俊宏教学名师工作坊(No:MSGZF-201818)。
关键词 肺炎支原体肺炎 D-二聚体 儿童 pneumonia,mycoplasma fibrin fragment d children
  • 相关文献

参考文献15

二级参考文献101

  • 1唐迎元,钟礼立,彭丹霞,黄寒.支原体肺炎患儿D-二聚体检测及临床意义[J].医学信息(医学与计算机应用),2014,0(22):298-299. 被引量:3
  • 2王俊,韩晓华,杨柏松,尚云晓,刘春峰,蔡栩栩.肺炎支原体肺炎患儿血清及诱导痰中白细胞介素-4及γ-干扰素的测定[J].中国实用儿科杂志,2005,20(9):543-545. 被引量:44
  • 3石树文,王晓钢.小儿支原体肺炎免疫状况与肺部影像学改变的预后分析[J].现代医药卫生,2007,23(9):1269-1271. 被引量:3
  • 4胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 5Tamura A, Matsubara K,Tanaka T,et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect, 2008, 57:223-228.
  • 6Lee KY, Lee HS, Hong JH,et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol, 2006,41: 263-265.
  • 7Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther,2008, 6:509-521.
  • 8Daxboeck F, Eisl B, Burghuber C, et al. Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl. Wien Klin Wochenschr,2007 ,119 :379-384.
  • 9Snijders D, Schoorl M, Schoorl M, et al. D-dimer levels in as- sessing severity and clinical outcome in patients with communi- ty-acquired pneumonia: a secondary analysis of a randomised clinical trial[ J ]. Eur J Intern Med, 2012,23 (5) : 436-441.
  • 10Chalmers JD, Singanayagam A, Scally C, et al. Admission D-di- mer can identify low-risk patients with community-acquired pneumonia[J]. Ann Emerg Med,2009,53(5) :633-638.

共引文献484

同被引文献102

引证文献10

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部